SOURCE: BBK Worldwide

BBK Worldwide

September 22, 2014 10:00 ET

BBK Worldwide's Mobile App Named a Finalist for the 2014 SCRIP Awards

BOSTON, MA--(Marketwired - September 22, 2014) - BBK Worldwide, a leading clinical trial marketing firm, today announced that its mobile app for patient and site engagement, My Clinical Study Buddy℠, is a finalist for a 2014 SCRIP Award, "Best Technological Development in Clinical Trials" category. Selected by a panel of esteemed judges, award winners will be announced at a ceremony in London on December 3.

Launched at this year's DIA Annual Meeting, BBK's My Clinical Study Buddy℠ helps pharmaceutical companies optimize the millions of dollars spent on patient recruitment annually by keeping patients engaged and actively involved throughout the study. My Clinical Study Buddy℠ provides enrolled patients with everything they need relating to their specific study, including appointment reminders and visit details, resources and videos, and maps and site contact links.

By leveraging the company's comprehensive recruitment platform TrialCentralNet℠ (TCN®) -- a system that streamlines, organizes, and provides on-demand analysis of all data, processes and activities -- the app is highly customizable and easily updatable in real-time based on user patterns and needs and/or protocol changes. Additionally, new apps can be built on the TCN® platform in weeks or a few months, versus several months to a year, saving sponsors valuable time, budget and resources.

The annual SCRIP Awards acknowledge and applaud the pharmaceutical industry's highest achievers across all parts of the value chain, and recognize both corporate and individual achievement. For more information about the SCRIP Awards and a full list of the finalists visit:

Tweet this: .@BBKWorldwide mobile app platform named a 2014 SCRIP award finalist #patientrecruitment #apps #mhealth

About BBK Worldwide

With more than three decades of experience across a wide variety of therapies and medicines, BBK Worldwide is the global leader in patient recruitment for the clinical trial industry. BBK's latest innovation is the introduction of adaptive recruitment -- a new specialty in clinical trial marketing proven to protect global enrollment integrity, specifically within a changing or threatened landscape. BBK is a privately held, women owned business, headquartered in Needham, Mass. For more information, visit:

Image Available:

Contact Information